# Inceptor Bio, LLC.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/inceptor-bio

- Industry: Biotechnology
- Headquarters: Morrisville, US
- Website: www.inceptor.bio
- Latest round: Series A
- Investors on record: 1

## About

Founded in 2020 and based in North Carolina, US, and founded in 2020 by its CEO, Shailesh Maingi, Inceptor Bio, LLC, operates as a provider of gene therapy technology platforms. In May 2022, Inceptor Bio, LLC. raised USD 37 million in series A funding led by returning investor Kineticos Ventures. As of 2022, the company has its manufacturing facilities in Gainesville and Florida. The company offers various platforms for the prevention and treatment of cancer through multiple cell therapies that include CAR-Macrophages, CAR-Natural Killer cells, and Gamma Delta T cells, CAR-T cells, which are used to locate and nullify cancer cells. The company also provides gene editing in vivo or ex vivo used to cure patients. The company plans to use the May 2022 funding to support the development of the CAR-T lead program, CAR-M, and CAR-NK platforms.

## Funding rounds

- Series A, date not disclosed — Kineticos Ventures

## Investors

- Kineticos Ventures (https://capitalatlas.ai/funds/kineticos-ventures) — Series A